{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:25:15Z","timestamp":1794385515312,"version":"4.9.0"},"reference-count":262,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2023YFA1800800"],"award-info":[{"award-number":["2023YFA1800800"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82225008"],"award-info":[{"award-number":["82225008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024T027AH"],"award-info":[{"award-number":["2024T027AH"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alcohol-associated liver disease (ALD) is a major global health challenge, with inflammation playing a central role in its progression. As inflammation emerges as a critical therapeutic target, ongoing research aims to unravel its underlying mechanisms. This review explores the immunological pathways of ALD, highlighting the roles of immune cells and their inflammatory mediators in disease onset and progression. We also examine the complex interactions between inflammatory cells and non-parenchymal liver cells, as well as their crosstalk with extra-hepatic organs, including the gut, adipose tissue, and nervous system. Furthermore, we summarize current clinical research on anti-inflammatory therapies and discuss promising therapeutic targets. Given the heterogeneity of ALD-associated inflammation, we emphasize the need for precision medicine to optimize treatment strategies and improve patient outcomes.<\/jats:p>","DOI":"10.1038\/s41423-025-01291-w","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T05:41:23Z","timestamp":1747806083000},"page":"1190-1204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Immunological mechanisms and emerging therapeutic targets in alcohol-associated liver disease"],"prefix":"10.1038","volume":"22","author":[{"given":"Haiyuan","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suthat","family":"Liangpunsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Iwakiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0836-2527","authenticated-orcid":false,"given":"Gyongyi","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2605-5697","authenticated-orcid":false,"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"1291_CR1","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/hep.22010","volume":"46","author":"S Zakhari","year":"2007","unstructured":"Zakhari S, Li TK. Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease. Hepatology. 2007;46:2032\u20139.","journal-title":"Hepatology"},{"key":"1291_CR2","doi-asserted-by":"crossref","unstructured":"Hyun J, Han J, Lee C, Yoon M., Jung Y. Pathophysiological aspects of alcohol metabolism in the liver. Int J Mol Sci. 2021;22:5717.","DOI":"10.3390\/ijms22115717"},{"key":"1291_CR3","unstructured":"World Health Organization. Global status report on alcohol and health 2018. Geneva: World Health Organization; 2018."},{"key":"1291_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-food-032519-051827","volume":"11","author":"HFJ Hendriks","year":"2020","unstructured":"Hendriks HFJ. Alcohol and human health: what is the evidence?. Annu Rev Food Sci Technol. 2020;11:1\u201321.","journal-title":"Annu Rev Food Sci Technol"},{"key":"1291_CR5","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1360-0443.2010.02899.x","volume":"105","author":"J Rehm","year":"2010","unstructured":"Rehm J, Baliunas D, Borges GL, Graham K, Irving H, Kehoe T, et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010;105:817\u201343.","journal-title":"Addiction"},{"key":"1291_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0168-8278(00)80420-1","volume":"32","author":"CS Lieber","year":"2000","unstructured":"Lieber CS. Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol. 2000;32:113\u201328.","journal-title":"J Hepatol"},{"key":"1291_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cld.2012.08.002","volume":"16","author":"AI Cederbaum","year":"2012","unstructured":"Cederbaum AI. Alcohol metabolism. Clin Liver Dis. 2012;16:667\u201385.","journal-title":"Clin Liver Dis"},{"key":"1291_CR8","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141:1572\u201385.","journal-title":"Gastroenterology"},{"key":"1291_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2165\/00003088-198713050-00001","volume":"13","author":"NH Holford","year":"1987","unstructured":"Holford NH. Clinical pharmacokinetics of ethanol. Clin Pharmacokinet. 1987;13:273\u201392.","journal-title":"Clin Pharmacokinet"},{"key":"1291_CR10","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1053\/j.gastro.2016.02.043","volume":"150","author":"S Liangpunsakul","year":"2016","unstructured":"Liangpunsakul S, Haber P, McCaughan GW. Alcoholic liver disease in Asia, Europe, and North America. Gastroenterology. 2016;150:1786\u201397.","journal-title":"Gastroenterology"},{"key":"1291_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.14309\/ajg.0000000000001596","volume":"117","author":"D Morales-Arr\u00e1ez","year":"2022","unstructured":"Morales-Arr\u00e1ez D, Ventura-Cots M, Altamirano J, Abraldes JG, Cruz-Lemini M, Thursz MR, et al. The MELd score is superior to the maddrey discriminant function score to predict short-term mortality in alcohol-associated hepatitis: a global study. Am J Gastroenterol. 2022;117:301\u201310.","journal-title":"Am J Gastroenterol"},{"key":"1291_CR12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jhep.2019.05.020","volume":"71","author":"R Parker","year":"2019","unstructured":"Parker R, Aithal GP, Becker U, Gleeson D, Masson S, Wyatt JI, et al. Natural history of histologically proven alcohol-related liver disease: a systematic review. J Hepatol. 2019;71:586\u201393.","journal-title":"J Hepatol"},{"key":"1291_CR13","doi-asserted-by":"publisher","first-page":"E177","DOI":"10.5888\/pcd12.150200","volume":"12","author":"SE Hadland","year":"2015","unstructured":"Hadland SE, Xuan Z, Blanchette JG, Heeren TC, Swahn MH, Naimi TS. Alcohol policies and alcoholic cirrhosis mortality in the United States. Prev Chronic Dis. 2015;12:E177.","journal-title":"Prev Chronic Dis"},{"key":"1291_CR14","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/hep.30761","volume":"70","author":"WE Rodriguez","year":"2019","unstructured":"Rodriguez WE, Wahlang B, Wang Y, Zhang J, Vadhanam MV, Joshi-Barve S, et al. Phosphodiesterase 4 inhibition as a therapeutic target for alcoholic liver disease: from bedside to bench. Hepatology. 2019;70:1958\u201371.","journal-title":"Hepatology"},{"key":"1291_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jhep.2018.10.023","volume":"70","author":"B Gao","year":"2019","unstructured":"Gao B, Ahmad MF, Nagy LE, Tsukamoto H. Inflammatory pathways in alcoholic steatohepatitis. J Hepatol. 2019;70:249\u201359.","journal-title":"J Hepatol"},{"key":"1291_CR16","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1053\/j.gastro.2016.01.025","volume":"150","author":"B Gao","year":"2016","unstructured":"Gao B, Tsukamoto H. Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe?. Gastroenterology. 2016;150:1704\u20139.","journal-title":"Gastroenterology"},{"key":"1291_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev-nutr-072610-145138","volume":"32","author":"HJ Wang","year":"2012","unstructured":"Wang HJ, Gao B, Zakhari S, Nagy LE. Inflammation in alcoholic liver disease. Annu Rev Nutr. 2012;32:343\u201368.","journal-title":"Annu Rev Nutr"},{"key":"1291_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/biomedicines8030050","volume":"8","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Zhang T, Kusumanchi P, Han S, Yang Z, Liangpunsakul S. Alcohol metabolizing enzymes, microsomal ethanol oxidizing system, cytochrome P450 2E1, catalase, and aldehyde dehydrogenase in alcohol-associated liver disease. Biomedicines. 2020;8:8.","journal-title":"Biomedicines"},{"key":"1291_CR19","first-page":"245","volume":"29","author":"S Zakhari","year":"2006","unstructured":"Zakhari S. Overview: how is alcohol metabolized by the body?. Alcohol Res Health. 2006;29:245\u201354.","journal-title":"Alcohol Res Health"},{"key":"1291_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37214-4","volume":"14","author":"T Thoudam","year":"2023","unstructured":"Thoudam T, Chanda D, Lee JY, Jung MK, Sinam IS, Kim BG, et al. Enhanced Ca(2+)-channeling complex formation at the ER-mitochondria interface underlies the pathogenesis of alcohol-associated liver disease. Nat Commun. 2023;14:1703.","journal-title":"Nat Commun"},{"key":"1291_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0003-9861(83)90406-X","volume":"220","author":"TM Donohue Jr.","year":"1983","unstructured":"Donohue TM Jr., Tuma DJ, Sorrell MF. Acetaldehyde adducts with proteins: binding of [14\u2009C]acetaldehyde to serum albumin. Arch Biochem Biophys. 1983;220:239\u201346.","journal-title":"Arch Biochem Biophys"},{"key":"1291_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1172\/JCI110043","volume":"67","author":"VJ Stevens","year":"1981","unstructured":"Stevens VJ, Fantl WJ, Newman CB, Sims RV, Cerami A, Peterson CM. Acetaldehyde adducts with hemoglobin. J Clin Invest. 1981;67:361\u20139.","journal-title":"J Clin Invest"},{"key":"1291_CR23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1530-0277.1982.tb05000.x","volume":"6","author":"WC Kenney","year":"1982","unstructured":"Kenney WC. Acetaldehyde adducts of phospholipids. Alcohol Clin Exp Res. 1982;6:412\u20136.","journal-title":"Alcohol Clin Exp Res"},{"key":"1291_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/em.21824","volume":"55","author":"PJ Brooks","year":"2014","unstructured":"Brooks PJ, Zakhari S. Acetaldehyde and the genome: beyond nuclear DNA adducts and carcinogenesis. Environ Mol Mutagen. 2014;55:77\u201391.","journal-title":"Environ Mol Mutagen"},{"key":"1291_CR25","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s42255-024-01063-2","volume":"6","author":"Y Fu","year":"2024","unstructured":"Fu Y, Mackowiak B, Lin YH, Maccioni L, Lehner T, Pan H, et al. Coordinated action of a gut-liver pathway drives alcohol detoxification and consumption. Nat Metab. 2024;6:1380\u201396.","journal-title":"Nat Metab"},{"key":"1291_CR26","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/hep.20673","volume":"41","author":"S Liangpunsakul","year":"2005","unstructured":"Liangpunsakul S, Kolwankar D, Pinto A, Gorski JC, Hall SD, Chalasani N. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics. Hepatology. 2005;41:1144\u201350.","journal-title":"Hepatology"},{"key":"1291_CR27","first-page":"277","volume":"27","author":"D Wu","year":"2003","unstructured":"Wu D, Cederbaum AI. Alcohol, oxidative stress, and free radical damage. Alcohol Res Health. 2003;27:277\u201384.","journal-title":"Alcohol Res Health"},{"key":"1291_CR28","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/hep.510230431","volume":"23","author":"DJ Tuma","year":"1996","unstructured":"Tuma DJ, Thiele GM, Xu D, Klassen LW, Sorrell MF. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology. 1996;23:872\u201380.","journal-title":"Hepatology"},{"key":"1291_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/diseases12040069","volume":"12","author":"G Scarlata","year":"2024","unstructured":"Scarlata G, Colaci C, Scarcella M, Dallio M, Federico A, Boccuto L, et al. The role of cytokines in the pathogenesis and treatment of alcoholic liver disease. Diseases. 2024;12:12.","journal-title":"Diseases"},{"key":"1291_CR30","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.jceh.2022.05.004","volume":"12","author":"NA Osna","year":"2022","unstructured":"Osna NA, Rasineni K, Ganesan M, Donohue TM Jr, Kharbanda KK. Pathogenesis of alcohol-associated liver disease. J Clin Exp Hepatol. 2022;12:1492\u2013513.","journal-title":"J Clin Exp Hepatol"},{"key":"1291_CR31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jcmgh.2016.05.010","volume":"2","author":"WY Chen","year":"2016","unstructured":"Chen WY, Zhang J, Ghare S, Barve S, McClain C, Joshi-Barve S. Acrolein is a pathogenic mediator of alcoholic liver disease and the scavenger hydralazine is protective in mice. Cell Mol Gastroenterol Hepatol. 2016;2:685\u2013700.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1291_CR32","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1021\/pr400362z","volume":"12","author":"G Xie","year":"2013","unstructured":"Xie G, Zhong W, Zheng X, Li Q, Qiu Y, Li H, et al. Chronic ethanol consumption alters mammalian gastrointestinal content metabolites. J Proteome Res. 2013;12:3297\u2013306.","journal-title":"J Proteome Res"},{"key":"1291_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","volume":"12","author":"A Louvet","year":"2015","unstructured":"Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015;12:231\u201342.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1291_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","volume":"148","author":"G Szabo","year":"2015","unstructured":"Szabo G. Gut-liver axis in alcoholic liver disease. Gastroenterology. 2015;148:30\u20136.","journal-title":"Gastroenterology"},{"key":"1291_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","volume":"13","author":"F Heymann","year":"2016","unstructured":"Heymann F, Tacke F. Immunology in the liver-from homeostasis to disease. Nat Rev Gastroenterol Hepatol. 2016;13:88\u2013110.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1291_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fimmu.2014.00221","volume":"5","author":"N Nakamoto","year":"2014","unstructured":"Nakamoto N, Kanai T. Role of toll-like receptors in immune activation and tolerance in the liver. Front Immunol. 2014;5:221.","journal-title":"Front Immunol"},{"key":"1291_CR37","first-page":"1","volume":"10","author":"T Xu","year":"2018","unstructured":"Xu T, Du Y, Fang XB, Chen H, Zhou DD, Wang Y, et al. New insights into Nod-like receptors (NLRs) in liver diseases. Int J Physiol Pathophysiol Pharm. 2018;10:1\u201316.","journal-title":"Int J Physiol Pathophysiol Pharm"},{"key":"1291_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/JLB.3MA0120-325RR","volume":"108","author":"J Wu","year":"2020","unstructured":"Wu J, Wu D, Ma K, Wang T, Shi G, Shao J, et al. Paeonol ameliorates murine alcohol liver disease via mycobiota-mediated Dectin-1\/IL-1\u03b2 signaling pathway. J Leukoc Biol. 2020;108:199\u2013214.","journal-title":"J Leukoc Biol"},{"key":"1291_CR39","doi-asserted-by":"publisher","first-page":"G15","DOI":"10.1152\/ajpgi.90512.2008","volume":"296","author":"V Stadlbauer","year":"2009","unstructured":"Stadlbauer V, Mookerjee RP, Wright GA, Davies NA, J\u00fcrgens G, Hallstr\u00f6m S, et al. Role of toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol. 2009;296:G15\u201322.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1291_CR40","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/hep.27779","volume":"62","author":"J Michelena","year":"2015","unstructured":"Michelena J, Altamirano J, Abraldes JG, Aff\u00f2 S, Morales-Ibanez O, Sancho-Bru P, et al. Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. Hepatology. 2015;62:762\u201372.","journal-title":"Hepatology"},{"key":"1291_CR41","doi-asserted-by":"crossref","unstructured":"Abenavoli L, Scarlata GGM, Paravati MR, Boccuto L., Luzza F., Scarpellini E. Gut microbiota and liver transplantation: immune mechanisms behind the rejection. Biomedicines. 2023;11:1792.","DOI":"10.3390\/biomedicines11071792"},{"key":"1291_CR42","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/00952990701407702","volume":"17","author":"SK Ramaiah","year":"2007","unstructured":"Ramaiah SK, Jaeschke H. Hepatic neutrophil infiltration in the pathogenesis of alcohol-induced liver injury. Toxicol Mech Methods. 2007;17:431\u201340.","journal-title":"Toxicol Mech Methods"},{"key":"1291_CR43","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1053\/gast.1997.v112.pm9178701","volume":"112","author":"K Saso","year":"1997","unstructured":"Saso K, Moehren G, Higashi K, Hoek JB. Differential inhibition of epidermal growth factor signaling pathways in rat hepatocytes by long-term ethanol treatment. Gastroenterology. 1997;112:2073\u201388.","journal-title":"Gastroenterology"},{"key":"1291_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3350\/cmh.2017.0067","volume":"24","author":"AM Cassard","year":"2018","unstructured":"Cassard AM, Ciocan D. Microbiota, a key player in alcoholic liver disease. Clin Mol Hepatol. 2018;24:100\u20137.","journal-title":"Clin Mol Hepatol"},{"key":"1291_CR45","doi-asserted-by":"crossref","unstructured":"Gao H, Jiang Y, Zeng G, Huda N., Thoudam T., Yang Z., et al. Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease. eGastroenterology 2024;2:e100104.","DOI":"10.1136\/egastro-2024-100104"},{"key":"1291_CR46","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1055\/s-0038-1670674","volume":"38","author":"Z Li","year":"2018","unstructured":"Li Z, Weinman SA. Regulation of hepatic inflammation via macrophage cell death. Semin Liver Dis. 2018;38:340\u201350.","journal-title":"Semin Liver Dis"},{"key":"1291_CR47","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1189\/jlb.6A0114-004RR","volume":"96","author":"M Wang","year":"2014","unstructured":"Wang M, You Q, Lor K, Chen F, Gao B, Ju C. Chronic alcohol ingestion modulates hepatic macrophage populations and functions in mice. J Leukoc Biol. 2014;96:657\u201365.","journal-title":"J Leukoc Biol"},{"key":"1291_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04669-7","volume":"7","author":"S Liangpunsakul","year":"2017","unstructured":"Liangpunsakul S, Toh E, Ross RA, Heathers LE, Chandler K, Oshodi A, et al. Quantity of alcohol drinking positively correlates with serum levels of endotoxin and markers of monocyte activation. Sci Rep. 2017;7:4462.","journal-title":"Sci Rep"},{"key":"1291_CR49","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1189\/jlb.3A0716-310R","volume":"102","author":"S Bala","year":"2017","unstructured":"Bala S, Csak T, Kodys K, Catalano D, Ambade A, Furi I, et al. Alcohol-induced miR-155 and HDAC11 inhibit negative regulators of the TLR4 pathway and lead to increased LPS responsiveness of Kupffer cells in alcoholic liver disease. J Leukoc Biol. 2017;102:487\u201398.","journal-title":"J Leukoc Biol"},{"key":"1291_CR50","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1074\/jbc.M112.419978","volume":"288","author":"JD Schilling","year":"2013","unstructured":"Schilling JD, Machkovech HM, He L, Sidhu R, Fujiwara H, Weber K, et al. Palmitate and lipopolysaccharide trigger synergistic ceramide production in primary macrophages. J Biol Chem. 2013;288:2923\u201332.","journal-title":"J Biol Chem"},{"key":"1291_CR51","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17:306\u201321.","journal-title":"Nat Rev Immunol"},{"key":"1291_CR52","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","volume":"66","author":"F Tacke","year":"2017","unstructured":"Tacke F. Targeting hepatic macrophages to treat liver diseases. J Hepatol. 2017;66:1300\u201312.","journal-title":"J Hepatol"},{"key":"1291_CR53","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1172\/JCI9020","volume":"106","author":"H Kono","year":"2000","unstructured":"Kono H, Rusyn I, Yin M, G\u00e4bele E, Yamashina S, Dikalova A, et al. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Investig. 2000;106:867\u201372.","journal-title":"J Clin Investig"},{"key":"1291_CR54","doi-asserted-by":"publisher","first-page":"G1570","DOI":"10.1152\/ajpgi.00399.2006","volume":"292","author":"K Abshagen","year":"2007","unstructured":"Abshagen K, Eipel C, Kalff JC, Menger MD, Vollmar B. Loss of NF-kappaB activation in Kupffer cell-depleted mice impairs liver regeneration after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1570\u20137.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1291_CR55","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jss.2013.02.033","volume":"183","author":"K Yang","year":"2013","unstructured":"Yang K, Du C, Cheng Y, Li Y, Gong J, Liu Z. Augmenter of liver regeneration promotes hepatic regeneration depending on the integrity of Kupffer cell in rat small-for-size liver transplantation. J Surg Res. 2013;183:922\u20138.","journal-title":"J Surg Res"},{"key":"1291_CR56","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00535-014-0992-5","volume":"50","author":"S Yoshiya","year":"2015","unstructured":"Yoshiya S, Shirabe K, Imai D, Toshima T, Yamashita Y, Ikegami T, et al. Blockade of the apelin-APJ system promotes mouse liver regeneration by activating Kupffer cells after partial hepatectomy. J Gastroenterol. 2015;50:573\u201382.","journal-title":"J Gastroenterol"},{"key":"1291_CR57","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/hep.29051","volume":"65","author":"JK Park","year":"2017","unstructured":"Park JK, Shao M, Kim MY, Baik SK, Cho MY, Utsumi T, et al. An endoplasmic reticulum protein, Nogo-B, facilitates alcoholic liver disease through regulation of kupffer cell polarization. Hepatology. 2017;65:1720\u201334.","journal-title":"Hepatology"},{"key":"1291_CR58","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/cmi.2015.104","volume":"13","author":"C Ju","year":"2016","unstructured":"Ju C, Tacke F. Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies. Cell Mol Immunol. 2016;13:316\u201327.","journal-title":"Cell Mol Immunol"},{"key":"1291_CR59","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.2353\/ajpath.2009.080632","volume":"174","author":"C Mitchell","year":"2009","unstructured":"Mitchell C, Couton D, Couty JP, Anson M, Crain AM, Bizet V, et al. Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. Am J Pathol. 2009;174:1766\u201375.","journal-title":"Am J Pathol"},{"key":"1291_CR60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.22952","volume":"50","author":"E Seki","year":"2009","unstructured":"Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, van Rooijen N, et al. CCR2 promotes hepatic fibrosis in mice. Hepatology. 2009;50:185\u201397.","journal-title":"Hepatology"},{"key":"1291_CR61","doi-asserted-by":"publisher","first-page":"853175","DOI":"10.1155\/2012\/853175","volume":"2012","author":"A Ambade","year":"2012","unstructured":"Ambade A, Mandrekar P. Oxidative stress and inflammation: essential partners in alcoholic liver disease. Int J Hepatol. 2012;2012:853175.","journal-title":"Int J Hepatol"},{"key":"1291_CR62","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","volume":"22","author":"QM Anstee","year":"2024","unstructured":"Anstee QM, Neuschwander-Tetri BA, Wai-Sun Wong V, Abdelmalek MF, Rodriguez-Araujo G, Landgren H, et al. Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study. Clin Gastroenterol Hepatol. 2024;22:124\u2013134.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1291_CR63","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.3389\/fimmu.2019.03112","volume":"10","author":"L Dou","year":"2019","unstructured":"Dou L, Shi X, He X, Gao Y. Macrophage phenotype and function in liver disorder. Front Immunol. 2019;10:3112.","journal-title":"Front Immunol"},{"key":"1291_CR64","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41573-019-0054-z","volume":"19","author":"T N\u00e9meth","year":"2020","unstructured":"N\u00e9meth T, Sperandio M, M\u00f3csai A. Neutrophils as emerging therapeutic targets. Nat Rev Drug Discov. 2020;19:253\u201375.","journal-title":"Nat Rev Drug Discov"},{"key":"1291_CR65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41423-020-00560-0","volume":"18","author":"K Liu","year":"2021","unstructured":"Liu K, Wang FS, Xu R. Neutrophils in liver diseases: pathogenesis and therapeutic targets. Cell Mol Immunol. 2021;18:38\u201344.","journal-title":"Cell Mol Immunol"},{"key":"1291_CR66","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/hep.27921","volume":"62","author":"B Chang","year":"2015","unstructured":"Chang B, Xu MJ, Zhou Z, Cai Y, Li M, Wang W, et al. Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1. Hepatology. 2015;62:1070\u201385.","journal-title":"Hepatology"},{"key":"1291_CR67","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/hep.28897","volume":"65","author":"S Das","year":"2017","unstructured":"Das S, Maras JS, Hussain MS, Sharma S, David P, Sukriti S, et al. Hyperoxidized albumin modulates neutrophils to induce oxidative stress and inflammation in severe alcoholic hepatitis. Hepatology. 2017;65:631\u201346.","journal-title":"Hepatology"},{"key":"1291_CR68","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jhep.2018.07.005","volume":"69","author":"TN Bukong","year":"2018","unstructured":"Bukong TN, Cho Y, Iracheta-Vellve A, Saha B, Lowe P, Adejumo A, et al. Abnormal neutrophil traps and impaired efferocytosis contribute to liver injury and sepsis severity after binge alcohol use. J Hepatol. 2018;69:1145\u201354.","journal-title":"J Hepatol"},{"key":"1291_CR69","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/hep.31680","volume":"74","author":"Y Cho","year":"2021","unstructured":"Cho Y, Szabo G. Two faces of neutrophils in liver disease development and progression. Hepatology. 2021;74:503\u201312.","journal-title":"Hepatology"},{"key":"1291_CR70","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0741-8329(02)00206-9","volume":"27","author":"AP Bautista","year":"2002","unstructured":"Bautista AP. Neutrophilic infiltration in alcoholic hepatitis. Alcohol. 2002;27:17\u201321.","journal-title":"Alcohol"},{"key":"1291_CR71","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1007\/s10620-021-07140-w","volume":"67","author":"K Vaz","year":"2022","unstructured":"Vaz K, Little R, Majeed A, Kemp W, Roberts SK. Determinants of short- and long-term outcomes of an australian cohort of patients admitted with alcoholic hepatitis. Dig Dis Sci. 2022;67:3356\u201365.","journal-title":"Dig Dis Sci"},{"key":"1291_CR72","doi-asserted-by":"publisher","first-page":"101352","DOI":"10.1016\/j.jcmgh.2024.04.009","volume":"18","author":"D Feng","year":"2024","unstructured":"Feng D, Hwang S, Guillot A, Wang Y, Guan Y, Chen C, et al. Inflammation in alcohol-associated hepatitis: pathogenesis and therapeutic targets. Cell Mol Gastroenterol Hepatol. 2024;18:101352.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1291_CR73","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/gutjnl-2011-301146","volume":"62","author":"S Aff\u00f2","year":"2013","unstructured":"Aff\u00f2 S, Dominguez M, Lozano JJ, Sancho-Bru P, Rodrigo-Torres D, Morales-Ibanez O, et al. Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis. Gut. 2013;62:452\u201360.","journal-title":"Gut"},{"key":"1291_CR74","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","volume":"136","author":"M Dominguez","year":"2009","unstructured":"Dominguez M, Miquel R, Colmenero J, Moreno M, Garc\u00eda-Pag\u00e1n JC, Bosch J, et al. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology. 2009;136:1639\u201350.","journal-title":"Gastroenterology"},{"key":"1291_CR75","doi-asserted-by":"crossref","unstructured":"Guan Y, Peiffer B, Feng D, Parra M.A., Wang Y., Fu Y., et al. IL-8+ neutrophils drive inexorable inflammation in severe alcohol-associated hepatitis. J Clin Investig. 2024;134:e178616.","DOI":"10.1172\/JCI178616"},{"key":"1291_CR76","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/hep.26419","volume":"58","author":"A Bertola","year":"2013","unstructured":"Bertola A, Park O, Gao B. Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin. Hepatology. 2013;58:1814\u201323.","journal-title":"Hepatology"},{"key":"1291_CR77","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcmgh.2024.03.001","volume":"18","author":"J Wang","year":"2024","unstructured":"Wang J, Wang X, Peng H, Dong Z, Liangpunsakul S, Zuo L, et al. Platelets in alcohol-associated liver disease: interaction with neutrophils. Cell Mol Gastroenterol Hepatol. 2024;18:41\u201352.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1291_CR78","doi-asserted-by":"crossref","unstructured":"Rycyk-Bojarzynska A, Kasztelan-Szczerbinska B, Cichoz-Lach H, Surdacka A., Rolinski J. Neutrophil PAD4 expression and its pivotal role in assessment of alcohol-related liver disease. Int J Mol Sci. 2024;25:7597.","DOI":"10.3390\/ijms25147597"},{"key":"1291_CR79","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2023.05.017","volume":"79","author":"RS Khan","year":"2023","unstructured":"Khan RS, Lalor PF, Thursz M, Newsome PN. The role of neutrophils in alcohol-related hepatitis. J Hepatol. 2023;79:1037\u201348.","journal-title":"J Hepatol"},{"key":"1291_CR80","doi-asserted-by":"publisher","first-page":"eadg1915","DOI":"10.1126\/scitranslmed.adg1915","volume":"16","author":"PT Nagesh","year":"2024","unstructured":"Nagesh PT, Cho Y, Zhuang Y, Babuta M, Ortega-Ribera M, Joshi R, et al. In vivo Bruton\u2019s tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis. Sci Transl Med. 2024;16:eadg1915.","journal-title":"Sci Transl Med"},{"key":"1291_CR81","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1136\/gutjnl-2023-331447","volume":"73","author":"M Babuta","year":"2024","unstructured":"Babuta M, Morel C, de Carvalho Ribeiro M, Calenda C, Ortega-Ribera M, Thevkar Nagesh P, et al. Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis. Gut. 2024;73:1854\u201369.","journal-title":"Gut"},{"key":"1291_CR82","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/gutjnl-2016-311861","volume":"66","author":"M Li","year":"2017","unstructured":"Li M, He Y, Zhou Z, Ramirez T, Gao Y, Gao Y, et al. MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47(phox)-oxidative stress pathway in neutrophils. Gut. 2017;66:705\u201315.","journal-title":"Gut"},{"key":"1291_CR83","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/JLB.5HR0120-459R","volume":"107","author":"M Hassani","year":"2020","unstructured":"Hassani M, Hellebrekers P, Chen N, van Aalst C, Bongers S, Hietbrink F, et al. On the origin of low-density neutrophils. J Leukoc Biol. 2020;107:809\u201318.","journal-title":"J Leukoc Biol"},{"key":"1291_CR84","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jhep.2022.08.029","volume":"78","author":"Y Cho","year":"2023","unstructured":"Cho Y, Bukong TN, Tornai D, Babuta M, Vlachos IS, Kanata E, et al. Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcohol-associated hepatitis. J Hepatol. 2023;78:28\u201344.","journal-title":"J Hepatol"},{"key":"1291_CR85","doi-asserted-by":"crossref","unstructured":"Guan Y, Feng D, Maccioni L, Wang Y., Gao B. New therapeutic target for alcohol-associated hepatitis (AH): AH-associated IL-8(+) neutrophils. eGastroenterology. 2024;2:e100166.","DOI":"10.1136\/egastro-2024-100166"},{"key":"1291_CR86","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/S0891-5849(01)00744-4","volume":"31","author":"O Niemela","year":"2001","unstructured":"Niemela O. Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radic Biol Med. 2001;31:1533\u20138.","journal-title":"Free Radic Biol Med"},{"key":"1291_CR87","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1365-3083.2009.02289.x","volume":"70","author":"MC Andrade","year":"2009","unstructured":"Andrade MC, Albernaz MJ, Ara\u00fajo MS, Santos BP, Teixeira-Carvalho A, Faria AM, et al. Short-term administration of ethanol in mice deviates antigen presentation activity towards B cells. Scand J Immunol. 2009;70:226\u201337.","journal-title":"Scand J Immunol"},{"key":"1291_CR88","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev-animal-031412-103651","volume":"1","author":"D Parra","year":"2013","unstructured":"Parra D, Takizawa F, Sunyer JO. Evolution of B cell immunity. Annu Rev Anim Biosci. 2013;1:65\u201397.","journal-title":"Annu Rev Anim Biosci"},{"key":"1291_CR89","first-page":"369","volume":"55","author":"MA Rodriguez","year":"1984","unstructured":"Rodriguez MA, Montano JD, Williams RC. Immunoglobulin production by peripheral blood mononuclear cells in patients with alcoholic liver disease. Clin Exp Immunol. 1984;55:369\u201376.","journal-title":"Clin Exp Immunol"},{"key":"1291_CR90","doi-asserted-by":"crossref","unstructured":"Ahmadi AR, Song G, Gao T, Ma J, Han X, Hu MW, et al. Discovery and characterization of cross-reactive intrahepatic antibodies in severe alcoholic hepatitis. Elife 2023;12:RP86678.","DOI":"10.7554\/eLife.86678.2"},{"key":"1291_CR91","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/alcalc\/agq076","volume":"46","author":"H Wang","year":"2011","unstructured":"Wang H, Zhou H, Mahler S, Chervenak R, Wolcott M. Alcohol affects the late differentiation of progenitor B cells. Alcohol Alcohol. 2011;46:26\u201332.","journal-title":"Alcohol Alcohol"},{"key":"1291_CR92","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2249.2009.04004.x","volume":"158","author":"B Massonnet","year":"2009","unstructured":"Massonnet B, Delwail A, Ayrault JM, Chagneau-Derrode C, Lecron JC, Silvain C. Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll-like receptor 9 activation. Clin Exp Immunol. 2009;158:115\u201324.","journal-title":"Clin Exp Immunol"},{"key":"1291_CR93","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1053\/j.gastro.2016.04.014","volume":"151","author":"L Moro-Sibilot","year":"2016","unstructured":"Moro-Sibilot L, Blanc P, Taillardet M, Bardel E, Couillault C, Boschetti G, et al. Mouse and human liver contain immunoglobulin A-secreting cells originating from peyer\u2019s patches and directed against intestinal antigens. Gastroenterology. 2016;151:311\u201323.","journal-title":"Gastroenterology"},{"key":"1291_CR94","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4254\/wjh.v5.i2.46","volume":"5","author":"LC Matos","year":"2013","unstructured":"Matos LC, Batista P, Monteiro N, Ribeiro J, Cipriano MA, Henriques P, et al. Lymphocyte subsets in alcoholic liver disease. World J Hepatol. 2013;5:46\u201355.","journal-title":"World J Hepatol"},{"key":"1291_CR95","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/0016-5085(93)90034-A","volume":"105","author":"A Chedid","year":"1993","unstructured":"Chedid A, Mendenhall CL, Moritz TE, French SW, Chen TS, Morgan TR, et al. Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275. Gastroenterology. 1993;105:254\u201366.","journal-title":"Gastroenterology"},{"key":"1291_CR96","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/hep.29242","volume":"66","author":"W Li","year":"2017","unstructured":"Li W, Amet T, Xing Y, Yang D, Liangpunsakul S, Puri P, et al. Alcohol abstinence ameliorates the dysregulated immune profiles in patients with alcoholic hepatitis: a prospective observational study. Hepatology. 2017;66:575\u201390.","journal-title":"Hepatology"},{"key":"1291_CR97","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0741-8329(01)00146-X","volume":"24","author":"K Song","year":"2001","unstructured":"Song K, Coleman RA, Alber C, Ballas ZK, Waldschmidt TJ, Mortari F, et al. TH1 cytokine response of CD57\u2009+\u2009T-cell subsets in healthy controls and patients with alcoholic liver disease. Alcohol. 2001;24:155\u201367.","journal-title":"Alcohol"},{"key":"1291_CR98","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/hep.22680","volume":"49","author":"A Lemmers","year":"2009","unstructured":"Lemmers A, Moreno C, Gustot T, Mar\u00e9chal R, Degr\u00e9 D, Demetter P, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009;49:646\u201357.","journal-title":"Hepatology"},{"key":"1291_CR99","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41423-018-0055-6","volume":"16","author":"B Gao","year":"2019","unstructured":"Gao B, Xiang X. Interleukin-22 from bench to bedside: a promising drug for epithelial repair. Cell Mol Immunol. 2019;16:666\u20137.","journal-title":"Cell Mol Immunol"},{"key":"1291_CR100","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.chom.2023.02.001","volume":"31","author":"S Zeng","year":"2023","unstructured":"Zeng S, Rosati E, Saggau C, Messner B, Chu H, Duan Y, et al. Candida albicans-specific Th17 cell-mediated response contributes to alcohol-associated liver disease. Cell Host Microbe. 2023;31:389\u2013404.e7.","journal-title":"Cell Host Microbe"},{"key":"1291_CR101","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/hep.26334","volume":"58","author":"F Lin","year":"2013","unstructured":"Lin F, Taylor NJ, Su H, Huang X, Hussain MJ, Abeles RD, et al. Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis. Hepatology. 2013;58:314\u201324.","journal-title":"Hepatology"},{"key":"1291_CR102","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","volume":"143","author":"F Meng","year":"2012","unstructured":"Meng F, Wang K, Aoyama T, Grivennikov SI, Paik Y, Scholten D, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology. 2012;143:765\u2013776.e3.","journal-title":"Gastroenterology"},{"key":"1291_CR103","doi-asserted-by":"crossref","unstructured":"Maccioni L, Guan Y, Kim M, Parra M.A., Peiffer B., Fu Y., et al. Opposite regulation of intestinal and intrahepatic CD8(+) T cells controls alcohol-associated liver disease progression. Gut. 2025.","DOI":"10.1136\/gutjnl-2024-334412"},{"key":"1291_CR104","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/acer.14323","volume":"44","author":"I Marrero","year":"2020","unstructured":"Marrero I, Maricic I, Morgan TR, Stolz AA, Schnabl B, Liu ZX, et al. Differential activation of unconventional T cells, including iNKT cells, in alcohol-related liver disease. Alcohol Clin Exp Res. 2020;44:1061\u201374.","journal-title":"Alcohol Clin Exp Res"},{"key":"1291_CR105","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1189\/JLB.0309135","volume":"86","author":"B Gao","year":"2009","unstructured":"Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol. 2009;86:513\u201328.","journal-title":"J Leukoc Biol"},{"key":"1291_CR106","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/hep.26471","volume":"58","author":"H Wang","year":"2013","unstructured":"Wang H, Feng D, Park O, Yin S, Gao B. Invariant NKT cell activation induces neutrophil accumulation and hepatitis: opposite regulation by IL-4 and IFN-\u03b3. Hepatology. 2013;58:1474\u201385.","journal-title":"Hepatology"},{"key":"1291_CR107","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/hep.27128","volume":"60","author":"S Yin","year":"2014","unstructured":"Yin S, Wang H, Bertola A, Feng D, Xu MJ, Wang Y, et al. Activation of invariant natural killer T cells impedes liver regeneration by way of both IFN-\u03b3- and IL-4-dependent mechanisms. Hepatology. 2014;60:1356\u201366.","journal-title":"Hepatology"},{"key":"1291_CR108","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jhep.2014.12.027","volume":"62","author":"K Cui","year":"2015","unstructured":"Cui K, Yan G, Xu C, Chen Y, Wang J, Zhou R, et al. Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1\u03b2 in mice. J Hepatol. 2015;62:1311\u20138.","journal-title":"J Hepatol"},{"key":"1291_CR109","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/cmi.2015.06","volume":"13","author":"S Mathews","year":"2016","unstructured":"Mathews S, Feng D, Maricic I, Ju C, Kumar V, Gao B. Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration. Cell Mol Immunol. 2016;13:206\u201316.","journal-title":"Cell Mol Immunol"},{"key":"1291_CR110","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.27632","volume":"61","author":"I Maricic","year":"2015","unstructured":"Maricic I, Sheng H, Marrero I, Seki E, Kisseleva T, Chaturvedi S, et al. Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice. Hepatology. 2015;61:1357\u201369.","journal-title":"Hepatology"},{"key":"1291_CR111","first-page":"e98","volume":"5","author":"A Kurioka","year":"2016","unstructured":"Kurioka A, Walker LJ, Klenerman P, Willberg CB. MAIT cells: new guardians of the liver. Clin Transl. Immunology. 2016;5:e98.","journal-title":"Immunology"},{"key":"1291_CR112","doi-asserted-by":"publisher","first-page":"e00052","DOI":"10.14309\/ctg.0000000000000052","volume":"10","author":"W Li","year":"2019","unstructured":"Li W, Lin EL, Liangpunsakul S, Lan J, Chalasani S, Rane S, et al. Alcohol abstinence does not fully reverse abnormalities of mucosal-associated invariant T cells in the blood of patients with alcoholic hepatitis. Clin Transl Gastroenterol. 2019;10:e00052.","journal-title":"Clin Transl Gastroenterol"},{"key":"1291_CR113","doi-asserted-by":"publisher","first-page":"E1771","DOI":"10.1073\/pnas.1222678110","volume":"110","author":"J L\u00f3pez-Sagaseta","year":"2013","unstructured":"L\u00f3pez-Sagaseta J, Dulberger CL, Crooks JE, Parks CD, Luoma AM, McFedries A, et al. The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins. Proc Natl Acad Sci USA. 2013;110:E1771\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1291_CR114","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/gutjnl-2017-314458","volume":"67","author":"A Riva","year":"2018","unstructured":"Riva A, Patel V, Kurioka A, Jeffery HC, Wright G, Tarff S, et al. Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease. Gut. 2018;67:918\u201330.","journal-title":"Gut"},{"key":"1291_CR115","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/gutjnl-2017-315284","volume":"67","author":"B Gao","year":"2018","unstructured":"Gao B, Ma J, Xiang X. MAIT cells: a novel therapeutic target for alcoholic liver disease?. Gut. 2018;67:784\u20136.","journal-title":"Gut"},{"key":"1291_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04450-y","volume":"9","author":"P Hegde","year":"2018","unstructured":"Hegde P, Weiss E, Paradis V, Wan J, Mabire M, Sukriti S, et al. Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver. Nat Commun. 2018;9:2146.","journal-title":"Nat Commun"},{"key":"1291_CR117","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","volume":"130","author":"S Radaeva","year":"2006","unstructured":"Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology. 2006;130:435\u201352.","journal-title":"Gastroenterology"},{"key":"1291_CR118","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1189\/jlb.1A0716-298RR","volume":"101","author":"F Zhang","year":"2017","unstructured":"Zhang F, Little A, Zhang H. Chronic alcohol consumption inhibits peripheral NK cell development and maturation by decreasing the availability of IL-15. J Leukoc Biol. 2017;101:1015\u201327.","journal-title":"J Leukoc Biol"},{"key":"1291_CR119","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nm0496-457","volume":"2","author":"S Ben-Eliyahu","year":"1996","unstructured":"Ben-Eliyahu S, Page GG, Yirmiya R, Taylor AN. Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nat Med. 1996;2:457\u201360.","journal-title":"Nat Med"},{"key":"1291_CR120","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1053\/j.gastro.2007.09.034","volume":"134","author":"WI Jeong","year":"2008","unstructured":"Jeong WI, Park O, Gao B. Abrogation of the antifibrotic effects of natural killer cells\/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology. 2008;134:248\u201358.","journal-title":"Gastroenterology"},{"key":"1291_CR121","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/hep.510250508","volume":"25","author":"FJ Laso","year":"1997","unstructured":"Laso FJ, Madruga JI, Gir\u00f3n JA, L\u00f3pez A, Ciudad J, San Miguel JF, et al. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption. Hepatology. 1997;25:1096\u2013100.","journal-title":"Hepatology"},{"key":"1291_CR122","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jcmgh.2022.09.010","volume":"15","author":"C Cheng","year":"2023","unstructured":"Cheng C, Zhang Q, Li Y, Jiang J, Xie L, Shen H, et al. Interplay between liver type 1 innate lymphoid cells and NK cells drives the development of alcoholic steatohepatitis. Cell Mol Gastroenterol Hepatol. 2023;15:261\u201374.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1291_CR123","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1007\/s00204-020-02780-9","volume":"94","author":"Q Tan","year":"2020","unstructured":"Tan Q, Liu Y, Deng X, Chen J, Tsai PJ, Chen PH, et al. Autophagy: a promising process for the treatment of acetaminophen-induced liver injury. Archives Toxicol. 2020;94:2925\u201338.","journal-title":"Archives Toxicol"},{"key":"1291_CR124","doi-asserted-by":"publisher","first-page":"917","DOI":"10.7326\/0003-4819-112-12-917","volume":"112","author":"GL Bird","year":"1990","unstructured":"Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med. 1990;112:917\u201320.","journal-title":"Ann Intern Med"},{"key":"1291_CR125","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/hep.1840130211","volume":"13","author":"A Khoruts","year":"1991","unstructured":"Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology. 1991;13:267\u201376.","journal-title":"Hepatology"},{"key":"1291_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jim-2017-000706","volume":"66","author":"CC Walline","year":"2018","unstructured":"Walline CC, Blum JS, Linton T, Mangiacarne D, Liangpunsakul S. Early activation of peripheral monocytes with hallmarks of M1 and M2 monocytic cells in excessive alcohol drinkers: a pilot study. J Investig Med. 2018;66:1\u20134.","journal-title":"J Investig Med"},{"key":"1291_CR127","doi-asserted-by":"publisher","first-page":"6978936","DOI":"10.1155\/2016\/6978936","volume":"2016","author":"M Molteni","year":"2016","unstructured":"Molteni M, Gemma S, Rossetti C. The role of toll-like receptor 4 in infectious and noninfectious inflammation. Mediators Inflamm. 2016;2016:6978936.","journal-title":"Mediators Inflamm"},{"key":"1291_CR128","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1007\/s11538-017-0336-8","volume":"79","author":"L Shafaghati","year":"2017","unstructured":"Shafaghati L, Razaghi-Moghadam Z, Mohammadnejad J. A systems biology approach to understanding alcoholic liver disease molecular mechanism: the development of static and dynamic models. Bull Math Biol. 2017;79:2450\u201373.","journal-title":"Bull Math Biol"},{"key":"1291_CR129","doi-asserted-by":"publisher","first-page":"G1047","DOI":"10.1152\/ajpgi.00016.2009","volume":"296","author":"Z Shen","year":"2009","unstructured":"Shen Z, Ajmo JM, Rogers CQ, Liang X, Le L, Murr MM, et al. Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1047\u201353.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1291_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1529-x","volume":"16","author":"F Ib\u00e1\u00f1ez","year":"2019","unstructured":"Ib\u00e1\u00f1ez F, Montesinos J, Ure\u00f1a-Peralta JR, Guerri C, Pascual M. TLR4 participates in the transmission of ethanol-induced neuroinflammation via astrocyte-derived extracellular vesicles. J Neuroinflammation. 2019;16:136.","journal-title":"J Neuroinflammation"},{"key":"1291_CR131","doi-asserted-by":"publisher","first-page":"630265","DOI":"10.1155\/2015\/630265","volume":"2015","author":"H Tsutsui","year":"2015","unstructured":"Tsutsui H, Cai X, Hayashi S. Interleukin-1 family cytokines in liver diseases. Mediators Inflamm. 2015;2015:630265.","journal-title":"Mediators Inflamm"},{"key":"1291_CR132","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/liv.12575","volume":"35","author":"CS Voican","year":"2015","unstructured":"Voican CS, Njik\u00e9-Nakseu M, Boujedidi H, Barri-Ova N, Bouchet-Delbos L, Agostini H, et al. Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease. Liver Int. 2015;35:967\u201378.","journal-title":"Liver Int"},{"key":"1291_CR133","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/liv.13430","volume":"37","author":"A Iracheta-Vellve","year":"2017","unstructured":"Iracheta-Vellve A, Petrasek J, Gyogyosi B, Bala S, Csak T, Kodys K, et al. Interleukin-1 inhibition facilitates recovery from liver injury and promotes regeneration of hepatocytes in alcoholic hepatitis in mice. Liver Int. 2017;37:968\u201373.","journal-title":"Liver Int"},{"key":"1291_CR134","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1172\/JCI60777","volume":"122","author":"J Petrasek","year":"2012","unstructured":"Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Investig. 2012;122:3476\u201389.","journal-title":"J Clin Investig"},{"key":"1291_CR135","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jhep.2024.01.031","volume":"80","author":"S Gawrieh","year":"2024","unstructured":"Gawrieh S, Dasarathy S, Tu W, Kamath PS, Chalasani NP, McClain CJ, et al. Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis. J Hepatol. 2024;80:684\u201393.","journal-title":"J Hepatol"},{"key":"1291_CR136","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12664-015-0565-4","volume":"34","author":"OP Patel","year":"2015","unstructured":"Patel OP, Noor MT, Kumar R, Thakur BS. Serum interleukin 8 and 12 levels predict severity and mortality in patients with alcoholic hepatitis. Indian J Gastroenterol. 2015;34:209\u201315.","journal-title":"Indian J Gastroenterol"},{"key":"1291_CR137","doi-asserted-by":"publisher","first-page":"G30","DOI":"10.1152\/ajpgi.00031.2015","volume":"309","author":"YS Roh","year":"2015","unstructured":"Roh YS, Zhang B, Loomba R, Seki E. TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration. Am J Physiol Gastrointest Liver Physiol. 2015;309:G30\u201341.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1291_CR138","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/gutjnl-2015-310344","volume":"66","author":"V Wieser","year":"2017","unstructured":"Wieser V, Adolph TE, Enrich B, Kuliopulos A, Kaser A, Tilg H, et al. Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors. Gut. 2017;66:930\u20138.","journal-title":"Gut"},{"key":"1291_CR139","doi-asserted-by":"publisher","first-page":"e55101","DOI":"10.1371\/journal.pone.0055101","volume":"8","author":"S St\u00f8y","year":"2013","unstructured":"St\u00f8y S, Sandahl TD, Dige AK, Agnholt J, Rasmussen TK, Gr\u00f8nb\u00e6k H, et al. Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course. PLoS One. 2013;8:e55101.","journal-title":"PLoS One"},{"key":"1291_CR140","doi-asserted-by":"crossref","unstructured":"Xu J, Ma HY, Liu X, Rosenthal S., Baglieri J., McCubbin R., et al. Blockade of IL-17 signaling reverses alcohol-induced liver injury and excessive alcohol drinking in mice. JCI Insight 2020;5:e131277.","DOI":"10.1172\/jci.insight.131277"},{"key":"1291_CR141","doi-asserted-by":"publisher","first-page":"e96053","DOI":"10.1371\/journal.pone.0096053","volume":"9","author":"CA Norris","year":"2014","unstructured":"Norris CA, He M, Kang LI, Ding MQ, Radder JE, Haynes MM, et al. Synthesis of IL-6 by hepatocytes is a normal response to common hepatic stimuli. PLoS One. 2014;9:e96053.","journal-title":"PLoS One"},{"key":"1291_CR142","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/00365513.2017.1420217","volume":"78","author":"M Gudowska-Sawczuk","year":"2018","unstructured":"Gudowska-Sawczuk M, Wrona A, Gruszewska E, Cylwik B, Panasiuk A, Flisiak R, et al. Serum level of interleukin-6 (IL-6) and N-terminal propeptide of procollagen type I (PINP) in patients with liver diseases. Scand J Clin Lab Investig. 2018;78:125\u201330.","journal-title":"Scand J Clin Lab Investig"},{"key":"1291_CR143","doi-asserted-by":"publisher","first-page":"e0128347","DOI":"10.1371\/journal.pone.0128347","volume":"10","author":"B Kasztelan-Szczerbi\u0144ska","year":"2015","unstructured":"Kasztelan-Szczerbi\u0144ska B, Surdacka A, Celi\u0144ski K, Roli\u0144ski J, Zwolak A, Mi\u0105cz S, et al. Prognostic significance of the systemic inflammatory and immune balance in alcoholic liver disease with a focus on gender-related differences. PLoS One. 2015;10:e0128347.","journal-title":"PLoS One"},{"key":"1291_CR144","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cytogfr.2018.01.002","volume":"39","author":"S Naseem","year":"2018","unstructured":"Naseem S, Hussain T, Manzoor S. Interleukin-6: a promising cytokine to support liver regeneration and adaptive immunity in liver pathologies. Cytokine Growth Factor Rev. 2018;39:36\u201345.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1291_CR145","doi-asserted-by":"publisher","first-page":"e66268","DOI":"10.1371\/journal.pone.0066268","volume":"8","author":"CH Chou","year":"2013","unstructured":"Chou CH, Lai SL, Chen CN, Lee PH, Peng FC, Kuo ML, et al. IL-6 regulates Mcl-1L expression through the JAK\/PI3K\/Akt\/CREB signaling pathway in hepatocytes: implication of an anti-apoptotic role during liver regeneration. PLoS ONE. 2013;8:e66268.","journal-title":"PLoS ONE"},{"key":"1291_CR146","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/hep.23909","volume":"52","author":"X Zhang","year":"2010","unstructured":"Zhang X, Tachibana S, Wang H, Hisada M, Williams GM, Gao B, et al. Interleukin-6 is an important mediator for mitochondrial DNA repair after alcoholic liver injury in mice. Hepatology. 2010;52:2137\u201347.","journal-title":"Hepatology"},{"key":"1291_CR147","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/hep.20184","volume":"39","author":"S Radaeva","year":"2004","unstructured":"Radaeva S, Sun R, Pan HN, Hong F, Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology. 2004;39:1332\u201342.","journal-title":"Hepatology"},{"key":"1291_CR148","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.cytogfr.2010.08.002","volume":"21","author":"E Witte","year":"2010","unstructured":"Witte E, Witte K, Warszawska K, Sabat R, Wolk K. Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev. 2010;21:365\u201379.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1291_CR149","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cyto.2016.08.023","volume":"98","author":"RF Carmo","year":"2017","unstructured":"Carmo RF, Cavalcanti MSM, Moura P. Role of Interleukin-22 in chronic liver injury. Cytokine. 2017;98:107\u201314.","journal-title":"Cytokine"},{"key":"1291_CR150","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","volume":"33","author":"JA Dudakov","year":"2015","unstructured":"Dudakov JA, Hanash AM, van den Brink MR. Interleukin-22: immunobiology and pathology. Annu Rev Immunol. 2015;33:747\u201385.","journal-title":"Annu Rev Immunol"},{"key":"1291_CR151","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/jgh.12032","volume":"28","author":"X Kong","year":"2013","unstructured":"Kong X, Feng D, Mathews S, Gao B. Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease. J Gastroenterol Hepatol. 2013;28:56\u201360.","journal-title":"J Gastroenterol Hepatol"},{"key":"1291_CR152","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/gutjnl-2018-317232","volume":"68","author":"T Hendrikx","year":"2019","unstructured":"Hendrikx T, Duan Y, Wang Y, Oh JH, Alexander LM, Huang W, et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice. Gut. 2019;68:1504\u201315.","journal-title":"Gut"},{"key":"1291_CR153","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.clinre.2015.05.008","volume":"39","author":"B Gao","year":"2015","unstructured":"Gao B, Shah VH. Combination therapy: new hope for alcoholic hepatitis?. Clin Res Hepatol Gastroenterol. 2015;39:S7\u2013s11.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1291_CR154","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1136\/gutjnl-2013-306098","volume":"63","author":"S Aff\u00f2","year":"2014","unstructured":"Aff\u00f2 S, Morales-Ibanez O, Rodrigo-Torres D, Altamirano J, Blaya D, Dapito DH, et al. CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis. Gut. 2014;63:1782\u201392.","journal-title":"Gut"},{"key":"1291_CR155","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1365-2249.2012.04609.x","volume":"169","author":"D Degr\u00e9","year":"2012","unstructured":"Degr\u00e9 D, Lemmers A, Gustot T, Ouziel R, Tr\u00e9po E, Demetter P, et al. Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates. Clin Exp Immunol. 2012;169:302\u201310.","journal-title":"Clin Exp Immunol"},{"key":"1291_CR156","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/hep.24599","volume":"54","author":"P Mandrekar","year":"2011","unstructured":"Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology. 2011;54:2185\u201397.","journal-title":"Hepatology"},{"key":"1291_CR157","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10408398.2017.1358139","volume":"59","author":"H Mollazadeh","year":"2019","unstructured":"Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A. Immune modulation by curcumin: The role of interleukin-10. Crit Rev Food Sci Nutr. 2019;59:89\u2013101.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1291_CR158","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-94-024-0921-5_5","volume":"941","author":"S Rutz","year":"2016","unstructured":"Rutz S, Ouyang W. Regulation of Interleukin-10 Expression. Adv Exp Med Biol. 2016;941:89\u2013116.","journal-title":"Adv Exp Med Biol"},{"key":"1291_CR159","doi-asserted-by":"publisher","first-page":"495156","DOI":"10.1155\/2013\/495156","volume":"2013","author":"H Kawaratani","year":"2013","unstructured":"Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, et al. The effect of inflammatory cytokines in alcoholic liver disease. Mediators Inflamm. 2013;2013:495156.","journal-title":"Mediators Inflamm"},{"key":"1291_CR160","doi-asserted-by":"publisher","first-page":"101344","DOI":"10.1016\/j.smim.2019.101344","volume":"44","author":"C Neumann","year":"2019","unstructured":"Neumann C, Scheffold A, Rutz S. Functions and regulation of T cell-derived interleukin-10. Semin Immunol. 2019;44:101344.","journal-title":"Semin Immunol"},{"key":"1291_CR161","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1530-0277.2010.01399.x","volume":"35","author":"AM Miller","year":"2011","unstructured":"Miller AM, Horiguchi N, Jeong WI, Radaeva S, Gao B. Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res. 2011;35:787\u201393.","journal-title":"Alcohol Clin Exp Res"},{"key":"1291_CR162","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jhep.2012.09.016","volume":"58","author":"JS Byun","year":"2013","unstructured":"Byun JS, Suh YG, Yi HS, Lee YS, Jeong WI. Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice. J Hepatol. 2013;58:342\u20139.","journal-title":"J Hepatol"},{"key":"1291_CR163","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/hep.27383","volume":"61","author":"R Lazaro","year":"2015","unstructured":"Lazaro R, Wu R, Lee S, Zhu NL, Chen CL, French SW, et al. Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice. Hepatology. 2015;61:129\u201340.","journal-title":"Hepatology"},{"key":"1291_CR164","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/hep.29129","volume":"66","author":"W Wang","year":"2017","unstructured":"Wang W, Xu MJ, Cai Y, Zhou Z, Cao H, Mukhopadhyay P, et al. Inflammation is independent of steatosis in a murine model of steatohepatitis. Hepatology. 2017;66:108\u201323.","journal-title":"Hepatology"},{"key":"1291_CR165","doi-asserted-by":"publisher","first-page":"22672","DOI":"10.1074\/jbc.M114.552141","volume":"289","author":"X Ge","year":"2014","unstructured":"Ge X, Antoine DJ, Lu Y, Arriazu E, Leung TM, Klepper AL, et al. High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD). J Biol Chem. 2014;289:22672\u201391.","journal-title":"J Biol Chem"},{"key":"1291_CR166","doi-asserted-by":"crossref","unstructured":"Cai Y, Xu MJ, Koritzinsky EH, Zhou Z., Wang W., Cao H., et al. Mitochondrial DNA-enriched microparticles promote acute-on-chronic alcoholic neutrophilia and hepatotoxicity. JCI Insight. 2017;2:e92634.","DOI":"10.1172\/jci.insight.92634"},{"key":"1291_CR167","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jhep.2015.11.020","volume":"64","author":"VK Verma","year":"2016","unstructured":"Verma VK, Li H, Wang R, Hirsova P, Mushref M, Liu Y, et al. Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles. J Hepatol. 2016;64:651\u201360.","journal-title":"J Hepatol"},{"key":"1291_CR168","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1084\/jem.20030286","volume":"197","author":"L Leng","year":"2003","unstructured":"Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, et al. MIF signal transduction initiated by binding to CD74. J Exp Med. 2003;197:1467\u201376.","journal-title":"J Exp Med"},{"key":"1291_CR169","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00109-015-1317-8","volume":"93","author":"EP van der Vorst","year":"2015","unstructured":"van der Vorst EP, D\u00f6ring Y, Weber C. Chemokines and their receptors in Atherosclerosis. J Mol Med (Berl). 2015;93:963\u201371.","journal-title":"J Mol Med (Berl)"},{"key":"1291_CR170","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0009-9120(01)00214-4","volume":"34","author":"T Kumagi","year":"2001","unstructured":"Kumagi T, Akbar F, Horiike N, Onji M. Increased serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues. Clin Biochem. 2001;34:189\u201393.","journal-title":"Clin Biochem"},{"key":"1291_CR171","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/hep.26169","volume":"57","author":"MA Barnes","year":"2013","unstructured":"Barnes MA, McMullen MR, Roychowdhury S, Pisano SG, Liu X, Stavitsky AB, et al. Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis. Hepatology. 2013;57:1980\u201391.","journal-title":"Hepatology"},{"key":"1291_CR172","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1053\/jhep.2003.50470","volume":"38","author":"S Joshi-Barve","year":"2003","unstructured":"Joshi-Barve S, Barve SS, Butt W, Klein J, McClain CJ. Inhibition of proteasome function leads to NF-kappaB-independent IL-8 expression in human hepatocytes. Hepatology. 2003;38:1178\u201387.","journal-title":"Hepatology"},{"key":"1291_CR173","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0741-8329(02)00200-8","volume":"27","author":"H Jaeschke","year":"2002","unstructured":"Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol. 2002;27:23\u20137.","journal-title":"Alcohol"},{"key":"1291_CR174","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s12276-022-00921-x","volume":"55","author":"HH Kim","year":"2023","unstructured":"Kim HH, Shim YR, Choi SE, Kim MH, Lee G, You HJ, et al. Catecholamine induces Kupffer cell apoptosis via growth differentiation factor 15 in alcohol-associated liver disease. Exp Mol Med. 2023;55:158\u201370.","journal-title":"Exp Mol Med"},{"key":"1291_CR175","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jcmgh.2023.07.009","volume":"16","author":"X Li","year":"2023","unstructured":"Li X, Huai Q, Zhu C, Zhang X, Xu W, Dai H, et al. GDF15 Ameliorates liver fibrosis by metabolic reprogramming of macrophages to acquire anti-inflammatory properties. Cell Mol Gastroenterol Hepatol. 2023;16:711\u201334.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1291_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80689-0","volume":"11","author":"N Takata","year":"2021","unstructured":"Takata N, Ishii KA, Takayama H, Nagashimada M, Kamoshita K, Tanaka T, et al. LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH. Sci Rep. 2021;11:555.","journal-title":"Sci Rep"},{"key":"1291_CR177","doi-asserted-by":"crossref","unstructured":"Xu H, Wu Z, Qin J, Li X., Xu F., Wang W., et al. Stressed hepatocyte sustains alcohol-associated hepatitis progression by producing leukocyte cell-derived chemotaxin 2. Gut. 2025, gutjnl-2024-334318.","DOI":"10.1136\/gutjnl-2024-334318"},{"key":"1291_CR178","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41575-018-0097-3","volume":"16","author":"J Gracia-Sancho","year":"2019","unstructured":"Gracia-Sancho J, Marrone G, Fern\u00e1ndez-Iglesias A. Hepatic microcirculation and mechanisms of portal hypertension. Nat Rev Gastroenterol Hepatol. 2019;16:221\u201334.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1291_CR179","doi-asserted-by":"publisher","first-page":"5964","DOI":"10.4049\/jimmunol.0901564","volume":"183","author":"SM Yeligar","year":"2009","unstructured":"Yeligar SM, Machida K, Tsukamoto H, Kalra VK. Ethanol augments RANTES\/CCL5 expression in rat liver sinusoidal endothelial cells and human endothelial cells via activation of NF-kappa B, HIF-1 alpha, and AP-1. J Immunol. 2009;183:5964\u201376.","journal-title":"J Immunol"},{"key":"1291_CR180","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24843-w","volume":"12","author":"M Liu","year":"2021","unstructured":"Liu M, Cao S, He L, Gao J, Arab JP, Cui H, et al. Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis. Nat Commun. 2021;12:4560.","journal-title":"Nat Commun"},{"key":"1291_CR181","first-page":"335","volume":"25","author":"AP Bautista","year":"1997","unstructured":"Bautista AP. Chronic alcohol intoxication induces hepatic injury through enhanced macrophage inflammatory protein-2 production and intercellular adhesion molecule-1 expression in the liver. Hepatology. 1997;25:335\u201342.","journal-title":"Hepatology"},{"key":"1291_CR182","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s12072-021-10165-y","volume":"15","author":"D Blaya","year":"2021","unstructured":"Blaya D, Rubio-Tom\u00e1s T, Rodrigo-Torres D, Lozano J, Coll M, Argemi J, et al. Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis. Hepatol Int. 2021;15:1006\u201317.","journal-title":"Hepatol Int"},{"key":"1291_CR183","doi-asserted-by":"publisher","first-page":"121457","DOI":"10.1016\/j.biomaterials.2022.121457","volume":"283","author":"LM Casey","year":"2022","unstructured":"Casey LM, Hughes KR, Saunders MN, Miller SD, Pearson RM, Shea LD. Mechanistic contributions of Kupffer cells and liver sinusoidal endothelial cells in nanoparticle-induced antigen-specific immune tolerance. Biomaterials. 2022;283:121457.","journal-title":"Biomaterials"},{"key":"1291_CR184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1034\/j.1600-0676.2001.210101.x","volume":"21","author":"G Svegliati-Baroni","year":"2001","unstructured":"Svegliati-Baroni G, Saccomanno S, van Goor H, Jansen P, Benedetti A, Moshage H. Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. Liver. 2001;21:1\u201312.","journal-title":"Liver"},{"key":"1291_CR185","first-page":"361","volume":"25","author":"A Casini","year":"1997","unstructured":"Casini A, Ceni E, Salzano R, Biondi P, Parola M, Galli A, et al. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology. 1997;25:361\u20137.","journal-title":"Hepatology"},{"key":"1291_CR186","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ni.2865","volume":"15","author":"J Mauer","year":"2014","unstructured":"Mauer J, Chaurasia B, Goldau J, Vogt MC, Ruud J, Nguyen KD, et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol. 2014;15:423\u201330.","journal-title":"Nat Immunol"},{"key":"1291_CR187","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1136\/gutjnl-2013-306294","volume":"63","author":"J Ehling","year":"2014","unstructured":"Ehling J, Bartneck M, Wei X, Gremse F, Fech V, M\u00f6ckel D, et al. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. Gut. 2014;63:1960\u201371.","journal-title":"Gut"},{"key":"1291_CR188","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/hep.26429","volume":"58","author":"JP Pradere","year":"2013","unstructured":"Pradere JP, Kluwe J, De Minicis S, Jiao JJ, Gwak GY, Dapito DH, et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology. 2013;58:1461\u201373.","journal-title":"Hepatology"},{"key":"1291_CR189","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0016-5085(97)70105-7","volume":"113","author":"H Sprenger","year":"1997","unstructured":"Sprenger H, Kaufmann A, Garn H, Lahme B, Gemsa D, Gressner AM. Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. Gastroenterology. 1997;113:277\u201385.","journal-title":"Gastroenterology"},{"key":"1291_CR190","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/0016-5085(95)90027-6","volume":"108","author":"Y Adachi","year":"1995","unstructured":"Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology. 1995;108:218\u201324.","journal-title":"Gastroenterology"},{"key":"1291_CR191","doi-asserted-by":"publisher","first-page":"e0174544","DOI":"10.1371\/journal.pone.0174544","volume":"12","author":"PP Lowe","year":"2017","unstructured":"Lowe PP, Gyongyosi B, Satishchandran A, Iracheta-Vellve A, Ambade A, Kodys K, et al. Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice. PLoS ONE. 2017;12:e0174544.","journal-title":"PLoS ONE"},{"key":"1291_CR192","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","volume":"67","author":"C Grander","year":"2018","unstructured":"Grander C, Adolph TE, Wieser V, Lowe P, Wrzosek L, Gyongyosi B, et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut. 2018;67:891\u2013901.","journal-title":"Gut"},{"key":"1291_CR193","doi-asserted-by":"publisher","first-page":"e53028","DOI":"10.1371\/journal.pone.0053028","volume":"8","author":"L Bull-Otterson","year":"2013","unstructured":"Bull-Otterson L, Feng W, Kirpich I, Wang Y, Qin X, Liu Y, et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One. 2013;8:e53028.","journal-title":"PLoS One"},{"key":"1291_CR194","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.alcohol.2008.12.009","volume":"43","author":"CB Forsyth","year":"2009","unstructured":"Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol. 2009;43:163\u201372.","journal-title":"Alcohol"},{"key":"1291_CR195","doi-asserted-by":"publisher","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","volume":"111","author":"S Leclercq","year":"2014","unstructured":"Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, St\u00e4rkel P, et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci USA. 2014;111:E4485\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1291_CR196","first-page":"3","volume":"31","author":"C Bode","year":"1993","unstructured":"Bode C, Kolepke R, Sch\u00e4fer K, Bode JC. Breath hydrogen excretion in patients with alcoholic liver disease-evidence of small intestinal bacterial overgrowth. Z Gastroenterol. 1993;31:3\u20137.","journal-title":"Z Gastroenterol"},{"key":"1291_CR197","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/hep.30832","volume":"71","author":"S Lang","year":"2020","unstructured":"Lang S, Duan Y, Liu J, Torralba MG, Kuelbs C, Ventura-Cots M, et al. Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis. Hepatology. 2020;71:522\u201338.","journal-title":"Hepatology"},{"key":"1291_CR198","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","volume":"575","author":"Y Duan","year":"2019","unstructured":"Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019;575:505\u201311.","journal-title":"Nature"},{"key":"1291_CR199","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/alcalc\/agx024","volume":"52","author":"JE Temko","year":"2017","unstructured":"Temko JE, Bouhlal S, Farokhnia M, Lee MR, Cryan JF, Leggio L. The microbiota, the gut and the brain in eating and alcohol use disorders: a \u2018M\u00e9nage \u00e0 Trois\u2019?. Alcohol Alcohol. 2017;52:403\u201313.","journal-title":"Alcohol Alcohol"},{"key":"1291_CR200","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fphys.2019.00185","volume":"10","author":"N Molinero","year":"2019","unstructured":"Molinero N, Ruiz L, S\u00e1nchez B, Margolles A, Delgado S. Intestinal bacteria interplay with bile and cholesterol metabolism: implications on host physiology. Front Physiol. 2019;10:185.","journal-title":"Front Physiol"},{"key":"1291_CR201","doi-asserted-by":"crossref","unstructured":"Park JW, Kim SE, Lee NY, Kim JH, Jung JH, Jang MK, et al. Role of microbiota-derived metabolites in alcoholic and non-alcoholic fatty liver diseases. Int J Mol Sci. 2021;23:426.","DOI":"10.3390\/ijms23010426"},{"key":"1291_CR202","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11978-0","volume":"10","author":"J Miyamoto","year":"2019","unstructured":"Miyamoto J, Igarashi M, Watanabe K, Karaki SI, Mukouyama H, Kishino S, et al. Gut microbiota confers host resistance to obesity by metabolizing dietary polyunsaturated fatty acids. Nat Commun. 2019;10:4007.","journal-title":"Nat Commun"},{"key":"1291_CR203","doi-asserted-by":"publisher","first-page":"1258062","DOI":"10.3389\/fphar.2023.1258062","volume":"14","author":"L Zhu","year":"2023","unstructured":"Zhu L, Wang Y, Pan CQ, Xing H. Gut microbiota in alcohol-related liver disease: pathophysiology and gut-brain cross talk. Front Pharm. 2023;14:1258062.","journal-title":"Front Pharm"},{"key":"1291_CR204","doi-asserted-by":"crossref","unstructured":"Shen H, Zhou L, Yang Y, Shu H, Wu D, Yang S, et al. The gut microbiota-produced vitamin B6 mitigates alcohol-associated liver disease by attenuating hepatic oxidative stress damage. Hepatol Commun. 2025;9:e0599.","DOI":"10.1097\/HC9.0000000000000599"},{"key":"1291_CR205","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.biopsych.2014.02.003","volume":"76","author":"S Leclercq","year":"2014","unstructured":"Leclercq S, De Saeger C, Delzenne N, de Timary P, St\u00e4rkel P. Role of inflammatory pathways, blood mononuclear cells, and gut-derived bacterial products in alcohol dependence. Biol Psychiatry. 2014;76:725\u201333.","journal-title":"Biol Psychiatry"},{"key":"1291_CR206","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1172\/JCI90562","volume":"127","author":"AM Yang","year":"2017","unstructured":"Yang AM, Inamine T, Hochrath K, Chen P, Wang L, Llorente C, et al. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest. 2017;127:2829\u201341.","journal-title":"J Clin Invest"},{"key":"1291_CR207","doi-asserted-by":"crossref","unstructured":"Duki\u0107 M, Radonji\u0107 T, Jovanovi\u0107 I, Zdravkovi\u0107 M, Todorovi\u0107 Z, Krai\u0161nik N, et al. Alcohol, inflammation, and microbiota in alcoholic liver disease. Int J Mol Sci. 2023;24:3735.","DOI":"10.3390\/ijms24043735"},{"key":"1291_CR208","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/gutjnl-2018-316307","volume":"68","author":"H Chu","year":"2019","unstructured":"Chu H, Duan Y, Yang L, Schnabl B. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. Gut. 2019;68:359\u201370.","journal-title":"Gut"},{"key":"1291_CR209","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9:3294.","journal-title":"Nat Commun"},{"key":"1291_CR210","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1136\/gutjnl-2020-321565","volume":"70","author":"L Wrzosek","year":"2021","unstructured":"Wrzosek L, Ciocan D, Hugot C, Spatz M, Dupeux M, Houron C, et al. Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury. Gut. 2021;70:1299\u2013308.","journal-title":"Gut"},{"key":"1291_CR211","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.chom.2024.06.008","volume":"32","author":"H Shen","year":"2024","unstructured":"Shen H, Zhou L, Zhang H, Yang Y, Jiang L, Wu D, et al. Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification. Cell Host Microbe. 2024;32:1331\u20131346.e6.","journal-title":"Cell Host Microbe"},{"key":"1291_CR212","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1083\/jcb.201409063","volume":"208","author":"JM Rutkowski","year":"2015","unstructured":"Rutkowski JM, Stern JH, Scherer PE. The cell biology of fat expansion. J Cell Biol. 2015;208:501\u201312.","journal-title":"J Cell Biol"},{"key":"1291_CR213","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2337\/diab.46.1.3","volume":"46","author":"G Boden","year":"1997","unstructured":"Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997;46:3\u201310.","journal-title":"Diabetes"},{"key":"1291_CR214","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1159\/000360509","volume":"32","author":"A Eguchi","year":"2014","unstructured":"Eguchi A, Feldstein AE. Adipocyte cell death, fatty liver disease and associated metabolic disorders. Dig Dis. 2014;32:579\u201385.","journal-title":"Dig Dis"},{"key":"1291_CR215","doi-asserted-by":"publisher","first-page":"e81949","DOI":"10.1371\/journal.pone.0081949","volume":"8","author":"T Tang","year":"2013","unstructured":"Tang T, Sui Y, Lian M, Li Z, Hua J. Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death. PLoS ONE. 2013;8:e81949.","journal-title":"PLoS ONE"},{"key":"1291_CR216","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2337\/db09-0925","volume":"59","author":"C Yeop Han","year":"2010","unstructured":"Yeop Han C, Kargi AY, Omer M, Chan CK, Wabitsch M, O'Brien KD, et al. Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation. Diabetes. 2010;59:386\u201396.","journal-title":"Diabetes"},{"key":"1291_CR217","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1074\/jbc.275.1.705","volume":"275","author":"BE Jones","year":"2000","unstructured":"Jones BE, Lo CR, Liu H, Srinivasan A, Streetz K, Valentino KL, et al. Hepatocytes sensitized to tumor necrosis factor-alpha cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways. J Biol Chem. 2000;275:705\u201312.","journal-title":"J Biol Chem"},{"key":"1291_CR218","doi-asserted-by":"publisher","first-page":"G583","DOI":"10.1152\/ajpgi.00422.2005","volume":"290","author":"RF Schwabe","year":"2006","unstructured":"Schwabe RF, Brenner DA. Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol. 2006;290:G583\u20139.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1291_CR219","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nrgastro.2017.116","volume":"15","author":"R Parker","year":"2018","unstructured":"Parker R, Kim S-J, Gao B. Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations. Nature Rev Gastroenterol Hepatol. 2018;15:50\u201359.","journal-title":"Nature Rev Gastroenterol Hepatol"},{"key":"1291_CR220","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.phrs.2007.09.014","volume":"56","author":"D Giannessi","year":"2007","unstructured":"Giannessi D, Maltinti M, Del Ry S. Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk. Pharmacol Res. 2007;56:459\u201367.","journal-title":"Pharmacol Res"},{"key":"1291_CR221","unstructured":"Ramakrishnan N, Auger K, Rahimi N, Jialal I. Biochemistry, Adiponectin. StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC.; 2025."},{"key":"1291_CR222","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19668-y","volume":"11","author":"H Xu","year":"2020","unstructured":"Xu H, Zhao Q, Song N, Yan Z, Lin R, Wu S, et al. AdipoR1\/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis. Nat Commun. 2020;11:5807.","journal-title":"Nat Commun"},{"key":"1291_CR223","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bbadis.2017.12.012","volume":"1864","author":"B Alzahrani","year":"2018","unstructured":"Alzahrani B, Iseli T, Ramezani-Moghadam M, Ho V, Wankell M, Sun EJ, et al. The role of AdipoR1 and AdipoR2 in liver fibrosis. Biochim Biophys Acta Mol Basis Dis. 2018;1864:700\u20138.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1291_CR224","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40139-015-0094-y","volume":"3","author":"PH Park","year":"2015","unstructured":"Park PH, Sanz-Garcia C, Nagy LE. Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver. Curr Pathobiol Rep. 2015;3:243\u201352.","journal-title":"Curr Pathobiol Rep"},{"key":"1291_CR225","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0168-8278(02)00102-2","volume":"37","author":"IA Leclercq","year":"2002","unstructured":"Leclercq IA, Farrell GC, Schriemer R, Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol. 2002;37:206\u201313.","journal-title":"J Hepatol"},{"key":"1291_CR226","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.lfs.2005.04.004","volume":"77","author":"J Shen","year":"2005","unstructured":"Shen J, Sakaida I, Uchida K, Terai S, Okita K. Leptin enhances TNF-alpha production via p38 and JNK MAPK in LPS-stimulated Kupffer cells. Life Sci. 2005;77:1502\u201315.","journal-title":"Life Sci"},{"key":"1291_CR227","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/hep.20965","volume":"42","author":"S Aleffi","year":"2005","unstructured":"Aleffi S, Petrai I, Bertolani C, Parola M, Colombatto S, Novo E, et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology. 2005;42:1339\u201348.","journal-title":"Hepatology"},{"key":"1291_CR228","doi-asserted-by":"crossref","unstructured":"Worth T. Could the gut give rise to alcohol addiction? Nature 2024.","DOI":"10.1038\/d41586-024-00667-8"},{"key":"1291_CR229","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.chom.2019.11.001","volume":"27","author":"B Seo","year":"2020","unstructured":"Seo B, Jeon K, Moon S, Lee K, Kim WK, Jeong H, et al. Roseburia spp. abundance associates with alcohol consumption in humans and its administration ameliorates alcoholic fatty liver in mice. Cell Host Microbe. 2020;27:25\u201340.e6.","journal-title":"Cell Host Microbe"},{"key":"1291_CR230","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/biof.1469","volume":"45","author":"Z Xu","year":"2019","unstructured":"Xu Z, Wang C, Dong X, Hu T, Wang L, Zhao W, et al. Chronic alcohol exposure induced gut microbiota dysbiosis and its correlations with neuropsychic behaviors and brain BDNF\/Gabra1 changes in mice. Biofactors. 2019;45:187\u201399.","journal-title":"Biofactors"},{"key":"1291_CR231","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/med.21752","volume":"41","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhu S, Ma N, Johnston LJ, Wu C, Ma X. Metabolites of microbiota response to tryptophan and intestinal mucosal immunity: A therapeutic target to control intestinal inflammation. Med Res Rev. 2021;41:1061\u201388.","journal-title":"Med Res Rev"},{"key":"1291_CR232","doi-asserted-by":"crossref","unstructured":"Day AW, Perez-Lozada J, DiLeo A, Blandino K, Maguire J, Kumamoto CA. Candida albicans Colonization Modulates Murine Ethanol Consumption and Behavioral Responses Through Elevation of Serum Prostaglandin E(2) and Impact on the Striatal Dopamine System. bioRxiv 2025.","DOI":"10.1101\/2025.02.25.640044"},{"key":"1291_CR233","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01829-6","volume":"12","author":"SC Bokoliya","year":"2024","unstructured":"Bokoliya SC, Russell J, Dorsett Y, Panier HA, Singh V, Daddi L, et al. Short-chain fatty acid valerate reduces voluntary alcohol intake in male mice. Microbiome. 2024;12:108.","journal-title":"Microbiome"},{"key":"1291_CR234","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fphar.2020.00355","volume":"11","author":"Y Yao","year":"2020","unstructured":"Yao Y, Zhang W, Ming R, Deng Q, Zuo A, Zhang S, et al. Noninvasive 40-Hz light flicker rescues circadian behavior and abnormal lipid metabolism induced by acute ethanol exposure via improving SIRT1 and the circadian clock in the liver-brain axis. Front Pharm. 2020;11:355.","journal-title":"Front Pharm"},{"key":"1291_CR235","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40139-016-0097-3","volume":"4","author":"HY Ma","year":"2016","unstructured":"Ma HY, Xu J, Liu X, Zhu Y, Gao B, Karin M, et al. The role of IL-17 signaling in regulation of the liver-brain axis and intestinal permeability in Alcoholic Liver Disease. Curr Pathobiol Rep. 2016;4:27\u201335.","journal-title":"Curr Pathobiol Rep"},{"key":"1291_CR236","doi-asserted-by":"publisher","first-page":"507","DOI":"10.15171\/apb.2017.063","volume":"7","author":"K Hajiasgharzadeh","year":"2017","unstructured":"Hajiasgharzadeh K, Baradaran B. Cholinergic anti-inflammatory pathway and the liver. Adv Pharm Bull. 2017;7:507\u201313.","journal-title":"Adv Pharm Bull"},{"key":"1291_CR237","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature01339","volume":"421","author":"H Wang","year":"2003","unstructured":"Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384\u20138.","journal-title":"Nature"},{"key":"1291_CR238","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/alcalc\/agz036","volume":"54","author":"N Hosseini","year":"2019","unstructured":"Hosseini N, Shor J, Szabo G. Alcoholic hepatitis: a review. Alcohol Alcohol. 2019;54:408\u201316.","journal-title":"Alcohol Alcohol"},{"key":"1291_CR239","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pharmthera.2017.06.007","volume":"180","author":"MJ Xu","year":"2017","unstructured":"Xu MJ, Zhou Z, Parker R, Gao B. Targeting inflammation for the treatment of alcoholic liver disease. Pharmacol Ther. 2017;180:77\u201389.","journal-title":"Pharmacol Ther"},{"key":"1291_CR240","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/hep.29240","volume":"66","author":"A Louvet","year":"2017","unstructured":"Louvet A, Labreuche J, Artru F, Bouthors A, Rolland B, Saffers P, et al. Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study. Hepatology. 2017;66:1464\u201373.","journal-title":"Hepatology"},{"key":"1291_CR241","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1192\/bjp.2018.13","volume":"212","author":"KC Morley","year":"2018","unstructured":"Morley KC, Baillie A, Fraser I, Furneaux-Bate A, Dore G, Roberts M, et al. Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial. Br J Psychiatry. 2018;212:362\u20139.","journal-title":"Br J Psychiatry"},{"key":"1291_CR242","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2190\/PM.42.3.b","volume":"42","author":"PM Miller","year":"2011","unstructured":"Miller PM, Book SW, Stewart SH. Medical treatment of alcohol dependence: a systematic review. Int J Psychiatry Med. 2011;42:227\u201366.","journal-title":"Int J Psychiatry Med"},{"key":"1291_CR243","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40265-021-01670-3","volume":"82","author":"EM Burnette","year":"2022","unstructured":"Burnette EM, Nieto SJ, Grodin EN, Meredith LR, Hurley B, Miotto K, et al. Novel agents for the pharmacological treatment of alcohol use disorder. Drugs. 2022;82:251\u201374.","journal-title":"Drugs"},{"key":"1291_CR244","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1053\/j.gastro.2018.05.011","volume":"155","author":"A Louvet","year":"2018","unstructured":"Louvet A, Thursz MR, Kim DJ, Labreuche J, Atkinson SR, Sidhu SS, et al. Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data from controlled trials. Gastroenterology. 2018;155:458\u2013468.e8.","journal-title":"Gastroenterology"},{"key":"1291_CR245","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/MCG.0000000000000674","volume":"51","author":"YS Lee","year":"2017","unstructured":"Lee YS, Kim HJ, Kim JH, Yoo YJ, Kim TS, Kang SH, et al. Treatment of severe alcoholic hepatitis with corticosteroid, pentoxifylline, or dual therapy: a systematic review and meta-analysis. J Clin Gastroenterol. 2017;51:364\u201377.","journal-title":"J Clin Gastroenterol"},{"key":"1291_CR246","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","volume":"372","author":"MR Thursz","year":"2015","unstructured":"Thursz MR, Richardson P, Allison M, Austin A, Bowers M, Day CP, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372:1619\u201328.","journal-title":"N Engl J Med"},{"key":"1291_CR247","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","volume":"81","author":"V Taru","year":"2024","unstructured":"Taru V, Szabo G, Mehal W, Reiberger T. Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation. Journal Hepatol. 2024;81:895\u2013910.","journal-title":"Journal Hepatol"},{"key":"1291_CR248","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.freeradbiomed.2013.09.009","volume":"65","author":"MA Abdelmegeed","year":"2013","unstructured":"Abdelmegeed MA, Banerjee A, Jang S, Yoo SH, Yun JW, Gonzalez FJ, et al. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. Free Radic Biol Med. 2013;65:1238\u201345.","journal-title":"Free Radic Biol Med"},{"key":"1291_CR249","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","volume":"365","author":"E Nguyen-Khac","year":"2011","unstructured":"Nguyen-Khac E, Thevenot T, Piquet MA, Benferhat S, Goria O, Chatelain D, et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med. 2011;365:1781\u20139.","journal-title":"N Engl J Med"},{"key":"1291_CR250","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","volume":"53","author":"C Moreno","year":"2010","unstructured":"Moreno C, Langlet P, Hittelet A, Lasser L, Degr\u00e9 D, Evrard S, et al. Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial. J Hepatol. 2010;53:1117\u201322.","journal-title":"J Hepatol"},{"key":"1291_CR251","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/07388551.2019.1709797","volume":"40","author":"A Basauri","year":"2020","unstructured":"Basauri A, Gonz\u00e1lez-Fern\u00e1ndez C, Fallanza M, Bringas E, Fernandez-Lopez R, Giner L, et al. Biochemical interactions between LPS and LPS-binding molecules. Crit Rev Biotechnol. 2020;40:292\u2013305.","journal-title":"Crit Rev Biotechnol"},{"key":"1291_CR252","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jhep.2022.07.006","volume":"77","author":"C Engelmann","year":"2022","unstructured":"Engelmann C, Habtesion A, Hassan M, Kerbert AJ, Hammerich L, Novelli S, et al. Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF. J Hepatol. 2022;77:1325\u201338.","journal-title":"J Hepatol"},{"key":"1291_CR253","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/hep.32478","volume":"76","author":"G Szabo","year":"2022","unstructured":"Szabo G, Mitchell M, McClain CJ, Dasarathy S, Barton B, McCullough AJ, et al. IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis. Hepatology. 2022;76:1058\u201368.","journal-title":"Hepatology"},{"key":"1291_CR254","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05719-2","volume":"22","author":"N Vergis","year":"2021","unstructured":"Vergis N, Patel V, Bogdanowicz K, Czyzewska-Khan J, Fiorentino F, Day E, et al. IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis. Trials. 2021;22:792.","journal-title":"Trials"},{"key":"1291_CR255","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/hep.30249","volume":"69","author":"A Ambade","year":"2019","unstructured":"Ambade A, Lowe P, Kodys K, Catalano D, Gyongyosi B, Cho Y, et al. Pharmacological inhibition of CCR2\/5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice. Hepatology. 2019;69:1105\u201321.","journal-title":"Hepatology"},{"key":"1291_CR256","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.ajpath.2012.12.010","volume":"182","author":"P Scheiermann","year":"2013","unstructured":"Scheiermann P, Bachmann M, Goren I, Zwissler B, Pfeilschifter J, M\u00fchl H. Application of interleukin-22 mediates protection in experimental acetaminophen-induced acute liver injury. Am J Pathol. 2013;182:1107\u201313.","journal-title":"Am J Pathol"},{"key":"1291_CR257","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jhep.2019.11.013","volume":"72","author":"X Xiang","year":"2020","unstructured":"Xiang X, Feng D, Hwang S, Ren T, Wang X, Trojnar E, et al. Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice. J Hepatol. 2020;72:736\u201345.","journal-title":"J Hepatol"},{"key":"1291_CR258","doi-asserted-by":"publisher","first-page":"2148129","DOI":"10.1155\/2016\/2148129","volume":"2016","author":"MB Khawar","year":"2016","unstructured":"Khawar MB, Azam F, Sheikh N, Abdul Mujeeb K. How does interleukin-22 mediate liver regeneration and prevent injury and fibrosis?. J Immunol Res. 2016;2016:2148129.","journal-title":"J Immunol Res"},{"key":"1291_CR259","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/hep.31046","volume":"72","author":"JP Arab","year":"2020","unstructured":"Arab JP, Sehrawat TS, Simonetto DA, Verma VK, Feng D, Tang T, et al. An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis. Hepatology. 2020;72:441\u201353.","journal-title":"Hepatology"},{"key":"1291_CR260","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1471-230X-13-151","volume":"13","author":"B Chang","year":"2013","unstructured":"Chang B, Sang L, Wang Y, Tong J, Zhang D, Wang B. The protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injury. BMC Gastroenterol. 2013;13:151.","journal-title":"BMC Gastroenterol"},{"key":"1291_CR261","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s12275-015-5239-5","volume":"53","author":"F Tian","year":"2015","unstructured":"Tian F, Chi F, Wang G, Liu X, Zhang Q, Chen Y, et al. Lactobacillus rhamnosus CCFM1107 treatment ameliorates alcohol-induced liver injury in a mouse model of chronic alcohol feeding. J Microbiol. 2015;53:856\u201363.","journal-title":"J Microbiol"},{"key":"1291_CR262","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/jgh.16257","volume":"38","author":"EL Yoon","year":"2023","unstructured":"Yoon EL, Kim W. Current and future treatment for alcoholic-related liver diseases. J Gastroenterol Hepatol. 2023;38:1218\u201326.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01291-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01291-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01291-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T22:02:57Z","timestamp":1759183377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01291-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":262,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1291"],"URL":"https:\/\/doi.org\/10.1038\/s41423-025-01291-w","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}